Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 31,472 | 21,950 | 0 | 0 | 0 |
| Cost of Goods | 20,161 | 15,088 | N/A | N/A | N/A |
| Gross Profit | 11,311 | 6,862 | N/A | N/A | N/A |
| Operating Expenses | 7,084 | 7,014 | 105 | 12 | 208 |
| Operating Income | 4,227 | -152 | -105 | -12 | -208 |
| Interest Expense | 180 | 178 | N/A | N/A | N/A |
| Other Income | 36 | 5 | 1 | 1 | 0 |
| Pre-tax Income | 4,083 | -325 | -103 | -11 | -208 |
| Income Tax | 2,116 | 248 | N/A | N/A | N/A |
| Net Income Continuous | 1,967 | -573 | -103 | -11 | -208 |
| Minority Interests | 32 | 63 | N/A | N/A | N/A |
| Net Income | $1,999 | $-510 | $-103 | $-11 | $-208 |
| EPS Basic Total Ops | 0.02 | -0.01 | -0.02 | -0.01 | -0.36 |
| EPS Basic Continuous Ops | 0.02 | -0.01 | -0.02 | -0.01 | -0.36 |
| EPS Diluted Total Ops | 0.01 | -0.01 | -0.02 | -0.01 | -0.36 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 | -0.02 | -0.01 | -0.36 |
| EBITDA(a) | $4,921 | $416 | $-105 | $-12 | $-208 |